The universal regulator of psychoemotional state. It stimulates the inhibitory processes; enhances a mental capacity due to attention focusing; gives an opportunity to get rid of morbid attraction. Specialists name it the “medicine of achieving the goals”.
Marketing authorization number Р № 003744/01 dated 16.11.2004. Russian Federation patent № 2097034
The perfect anti-stress drug for the entire family. It decreases a tension, enhance mood, increases working capacity, normalizes the sleep, decrease toxic effect in case of by poisoning. It is indicated for the treatment of arterial hypertension, vegetative-vascular dystonia, residual effects after brain injuries, acute ischemic stroke.
Marketing authorization number Р № ЛСР -001431/07 dated 09.07.2007. Russian Federation patent № 2097034, Russian Federation patent № 2082398
The first medicine for a newborn. The drug enhances the energy production in cells in ATP form, has anti-hypoxic and antioxidant properties, improves the pregnancy course and outcome, reduces alcohol intoxication, stimulates gastric acid secretion and increases the appetite.
Marketing authorization number Р № 000176/01 dated 06.06.2008. Russian Federation patent № 2039556.
The drug with antioxidant properties; it has ability to normalize the oxidation-reduction processes and oxygen utilization in tissues. It also increases myocardial contractility and physical tolerance, improves the quality of life of patients with heart failure.
Marketing authorization number № ЛС-000499. Russian Federation patent № 2096034.
Pharmacological group: Drug for treatment of alcoholism
ATC code [А11JC]
Biotredin® acts as a tissue metabolic regulator, enhances mental capacity, has a therapeutic effect on alcohol withdrawal syndrome, decreases attraction to alcohol. L-threonine in the presence of pyridoxine (vitamin B6) decomposes into glycine amino acid and acetaldehyde (acetic acid), which simultaneously stimulate inhibitory processes, oxidation-reduction reactions, cell respiration processes and ATP synthesis; as a result, Biotredin® is able to:
L-threonine and pyridoxine are completely metabolized into water and carbon dioxide. Accumulation in the organism doesn’t occur.
Biotredin® is prescribed to children, teenagers and adults with decrease of mental efficiency and ability to concentrate. Biotredin® is indicated in persons with alcohol abuse, patients with chronic alcoholism in cases of actualization of chronic alcoholism combined with affective (irritability, low mood, internal discomfort), sensory (hunger) and ideational (thoughts about alcohol) disorders, for treatment of alcohol abstinence syndrome, and also for maintenance of remission.
Pharmacological group: Metabolic drug
ATC code N06BX
Glycine acts as a metabolic regulator, normalizes and activates processes of defensive inhibition in central nervous system (CNS), decreases psycho-emotional tension, enhances mental capacity. Glycine has a glycine- and GABA-ergic effect, alpha1-adrenoblocking, anti-oxidant and anti-toxic effects; it regulates activity of glutamate receptors (NMDA); as a result, Glycine is able to:
Glycine easily penetrates into most biological fluids and tissues, including the brain; is metabolized into water and carbon dioxide, its accumulation in tissues does not occur.
Pharmacological group: Metabolic drug
ATC code А15
Limontar® acts as a tissue metabolic regulator, enhances the oxidation-reduction processes and the production of ATP; as a result, it has antioxidant and anti-hypoxic properties and is able to:
Citric and succinic acid are completely metabolized into water and carbon dioxide; their accumulation in the organism doesn’t occur.
Limontar® is used: as a drug for increasing of non-specific reactivity of the organism of pregnant women, enhancing their adaptation and compensation abilities for prevention of hypoxia complications, fetus hypotrophy, and pregnancy loss. It is used for prevention of alcohol intoxication; in treatment of acute alcohol intoxication of mild or medium severity for decreasing of the toxic effect of alcohol and post-toxic disorders; in complex therapy of dipsomania in patients with alcohol addiction; for complex treatment of asthenovegetative disorder (common weakness, decreasing of efficiency, loss of appetite) at a periods of alcohol abstinence syndrome. Limontar® is also used as a test-breakfast in analysis of secretory and acid-forming gastric functions (diagnostic utility of Limontar® and that of histamine are equal).
Pharmacological group: Antioxidant drug
ATC code C01EX
Eltacin® contains the mix of nonessential amino acids: Glycine, L-glutamic acid and L-cystine. Eltacin® acts as a metabolic regulator: increases the intracellular level of glutathione and glutathione-dependent enzymes, normalizes oxidation-reduction processes and oxygen utilization in tissues; as a result, the drug is able to:
The drug is indicated for treatment of the functional class I-III chronic heart failure (on the background of a basic therapy).
Your message has been succesfully sent!